172 related articles for article (PubMed ID: 36860911)
1. Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Memory-Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand.
Ando M; Kondo T; Tomisato W; Ito M; Shichino S; Srirat T; Mise-Omata S; Nakagawara K; Yoshimura A
Cancer Res Commun; 2021 Oct; 1(1):41-55. PubMed ID: 36860911
[TBL] [Abstract][Full Text] [Related]
2. The NOTCH-FOXM1 Axis Plays a Key Role in Mitochondrial Biogenesis in the Induction of Human Stem Cell Memory-like CAR-T Cells.
Kondo T; Ando M; Nagai N; Tomisato W; Srirat T; Liu B; Mise-Omata S; Ikeda M; Chikuma S; Nishimasu H; Nureki O; Ohmura M; Hayakawa N; Hishiki T; Uchibori R; Ozawa K; Yoshimura A
Cancer Res; 2020 Feb; 80(3):471-483. PubMed ID: 31767627
[TBL] [Abstract][Full Text] [Related]
3. Generation and application of human induced-stem cell memory T cells for adoptive immunotherapy.
Kondo T; Imura Y; Chikuma S; Hibino S; Omata-Mise S; Ando M; Akanuma T; Iizuka M; Sakai R; Morita R; Yoshimura A
Cancer Sci; 2018 Jul; 109(7):2130-2140. PubMed ID: 29790621
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Generation of Stem Cell Memory-Like T Cells from Activated T Cells.
Ando M; Ikeda M; Yoshimura A; Kondo T
Methods Mol Biol; 2020; 2111():127-139. PubMed ID: 31933204
[TBL] [Abstract][Full Text] [Related]
5. Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy.
Kondo T; Morita R; Okuzono Y; Nakatsukasa H; Sekiya T; Chikuma S; Shichita T; Kanamori M; Kubo M; Koga K; Miyazaki T; Kassai Y; Yoshimura A
Nat Commun; 2017 May; 8():15338. PubMed ID: 28530241
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Conversion of Activated T Cells into Stem Cell Memory-Like T Cells.
Kondo T; Imura Y; Ando M; Chikuma S; Yoshimura A
Methods Mol Biol; 2019; 2048():41-51. PubMed ID: 31396927
[TBL] [Abstract][Full Text] [Related]
7. IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype.
Alizadeh D; Wong RA; Yang X; Wang D; Pecoraro JR; Kuo CF; Aguilar B; Qi Y; Ann DK; Starr R; Urak R; Wang X; Forman SJ; Brown CE
Cancer Immunol Res; 2019 May; 7(5):759-772. PubMed ID: 30890531
[TBL] [Abstract][Full Text] [Related]
8. Generation of CAR-T
Hu J; Liu X
Int Immunopharmacol; 2024 Jul; 136():112379. PubMed ID: 38833844
[TBL] [Abstract][Full Text] [Related]
9. Next-Generation Manufacturing Protocols Enriching T
Arcangeli S; Falcone L; Camisa B; De Girardi F; Biondi M; Giglio F; Ciceri F; Bonini C; Bondanza A; Casucci M
Front Immunol; 2020; 11():1217. PubMed ID: 32636841
[TBL] [Abstract][Full Text] [Related]
10. Efficient derivation of chimeric-antigen receptor-modified T
Kranz E; Kuhlmann CJ; Chan J; Kim PY; Chen ISY; Kamata M
Front Immunol; 2022; 13():877682. PubMed ID: 35967430
[TBL] [Abstract][Full Text] [Related]
11. CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies.
Gulden G; Sert B; Teymur T; Ay Y; Tiryaki NN; Mishra AK; Ovali E; Tarhan N; Tastan C
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851194
[TBL] [Abstract][Full Text] [Related]
12. T
Meyran D; Zhu JJ; Butler J; Tantalo D; MacDonald S; Nguyen TN; Wang M; Thio N; D'Souza C; Qin VM; Slaney C; Harrison A; Sek K; Petrone P; Thia K; Giuffrida L; Scott AM; Terry RL; Tran B; Desai J; Prince HM; Harrison SJ; Beavis PA; Kershaw MH; Solomon B; Ekert PG; Trapani JA; Darcy PK; Neeson PJ
Sci Transl Med; 2023 Apr; 15(690):eabk1900. PubMed ID: 37018415
[TBL] [Abstract][Full Text] [Related]
13.
Suematsu M; Yagyu S; Nagao N; Kubota S; Shimizu Y; Tanaka M; Nakazawa Y; Imamura T
Front Immunol; 2022; 13():770132. PubMed ID: 35154098
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study of the fourth-generation CAR-T cells targeting CS1 in the treatment of refractory and recurrent multiple myeloma].
Feng DD; Chen XH; Guo JJ; Wang KK; Zhang XM; Gao JM
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):657-665. PubMed ID: 34289557
[No Abstract] [Full Text] [Related]
15. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
[TBL] [Abstract][Full Text] [Related]
16. Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity.
Torres Chavez A; McKenna MK; Canestrari E; Dann CT; Ramos CA; Lulla P; Leen AM; Vera JF; Watanabe N
J Immunother Cancer; 2019 Nov; 7(1):330. PubMed ID: 31779709
[TBL] [Abstract][Full Text] [Related]
17. Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.
Alvarez-Fernández C; Escribà-Garcia L; Caballero AC; Escudero-López E; Ujaldón-Miró C; Montserrat-Torres R; Pujol-Fernández P; Sierra J; Briones J
Clin Transl Immunology; 2021; 10(4):e1268. PubMed ID: 33968404
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of
Xu T; Wang C; Chen X; Bai J; Wang E; Sun M
Immunotherapy; 2022 Dec; 14(18):1457-1466. PubMed ID: 36597720
[TBL] [Abstract][Full Text] [Related]
19.
Bonte S; de Munter S; Billiet L; Goetgeluk G; Ingels J; Jansen H; Pille M; de Cock L; Weening K; Taghon T; Leclercq G; Vandekerckhove B; Kerre T
Oncoimmunology; 2021; 10(1):1954800. PubMed ID: 34367734
[TBL] [Abstract][Full Text] [Related]
20. Memory T cell, exhaustion, and tumor immunity.
Ando M; Ito M; Srirat T; Kondo T; Yoshimura A
Immunol Med; 2020 Mar; 43(1):1-9. PubMed ID: 31822213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
